Press release
Circadian Rhythm Sleep Disorders Market New Product Development & Latest Trends
Circadian Rhythm Sleep Disorders Market
Circadian Rhythm Sleep Disorders (CRSD) are a group of conditions in which a person's internal biological clock is misaligned with external environmental cues such as light and social schedules. Disorders under this category include delayed sleep phase disorder, advanced sleep phase disorder, irregular sleep-wake rhythm, non-24-hour sleep-wake disorder, and shift work disorder. These conditions can result in insomnia, excessive sleepiness, and reduced quality of life.
The rising prevalence of sleep disorders, greater awareness of sleep health, and increased demand for pharmacological and non-pharmacological treatments are fueling growth in the circadian rhythm sleep disorders market. With innovation in chronotherapy, melatonin analogs, and digital sleep monitoring technologies, this market is emerging as an important segment of the broader sleep medicine industry.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72108
Market Overview
The global circadian rhythm sleep disorders market was valued at USD 880 million in 2024 and is projected to reach USD 1.55 billion by 2034, expanding at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period.
Key market highlights include:
• Growing awareness of sleep health as a public health priority.
• Rising prevalence of shift work disorder due to modern work patterns.
• Expanding use of pharmacological therapies (melatonin, hypnotics, wake-promoting agents).
• Growth of digital sleep monitoring tools and wearables.
Barriers include underdiagnosis of CRSD, stigma associated with sleep disorders, and limited availability of sleep medicine specialists in emerging markets.
Leading players include Vanda Pharmaceuticals, Takeda Pharmaceutical Company, Eisai Co., Ltd., Jazz Pharmaceuticals, Philips Healthcare, and Fitbit (Google), all of which are expanding portfolios in pharmacology, digital health, and sleep monitoring.
Segmentation Analysis
By Product
• Pharmacological therapies
o Melatonin and melatonin receptor agonists
o Hypnotics and sedatives
o Wake-promoting agents (modafinil, armodafinil)
• Light therapy devices
• Wearable sleep monitoring devices
• Digital therapeutic platforms (CBT-I, mobile health apps)
By Platform
• Hospitals & sleep clinics
• Specialty neurology and psychiatry centers
• Ambulatory care facilities
• Home-based monitoring platforms
By Technology
• Pharmacological chronotherapy
• Light-based therapy
• Digital cognitive behavioral therapy (CBT-I)
• AI-based sleep monitoring and analytics
By End Use
• Adults (18-64 years)
• Geriatric patients (65+ years)
• Pediatric and adolescent populations
By Application
• Delayed sleep phase disorder (DSPD)
• Advanced sleep phase disorder (ASPD)
• Irregular sleep-wake rhythm disorder
• Non-24-hour sleep-wake disorder (Non-24)
• Shift work disorder
Segmentation Summary
Pharmacological therapies dominate the market, but digital therapeutics and wearable devices are rapidly gaining adoption. Hospitals and sleep clinics lead in diagnosis and treatment, while home-based solutions and telemedicine platforms are expanding access.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72108/circadian-rhythm-sleep-disorders-market
Regional Analysis
North America
• Largest market share due to advanced sleep medicine infrastructure, strong awareness campaigns, and high prevalence of shift work-related disorders.
• The U.S. leads with FDA-approved therapies (e.g., melatonin analogs) and widespread adoption of digital sleep technologies.
Europe
• Significant growth supported by public health initiatives promoting sleep health.
• Germany, France, and the UK dominate, with increasing use of light therapy and digital monitoring.
Asia-Pacific
• Fastest-growing region, driven by urbanization, rising shift work populations, and growing awareness of sleep disorders.
• Japan, China, and India are major contributors, with expanding telehealth adoption.
Middle East & Africa
• Gradual growth due to low awareness and underdiagnosis but improving through private healthcare initiatives in Gulf nations.
Latin America
• Brazil, Mexico, and Argentina are emerging markets, with growing adoption of sleep monitoring devices and pharmacological treatments.
Regional Summary
North America and Europe dominate revenues, while Asia-Pacific is forecast to deliver the fastest growth due to increasing demand for sleep diagnostics and therapies in large, urban populations.
Market Dynamics
Key Growth Drivers
• Rising prevalence of circadian rhythm disorders due to lifestyle and work-related changes.
• Expanding use of digital sleep monitoring devices and mobile health apps.
• Growth of pharmacological treatments, especially melatonin receptor agonists.
• Increasing public and private funding for sleep health research.
Key Challenges
• Underdiagnosis and misdiagnosis of CRSD.
• High treatment costs in advanced healthcare systems.
• Stigma and low awareness in developing countries.
• Limited access to sleep medicine specialists.
Latest Trends
• Development of next-generation melatonin analogs and wake-promoting drugs.
• Growth of wearable devices with AI-based analytics.
• Expansion of digital CBT-I platforms for behavioral interventions.
• Increasing corporate wellness programs addressing sleep health.
Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72108
Competitor Analysis
Major Players:
• Vanda Pharmaceuticals Inc.
• Takeda Pharmaceutical Company Limited
• Eisai Co., Ltd.
• Jazz Pharmaceuticals plc
• Koninklijke Philips N.V.
• Fitbit (Google LLC)
• ResMed Inc.
• Idorsia Pharmaceuticals
• Compumedics Limited
• Medtronic plc
Competitive Summary
The CRSD market is diverse and innovation-driven, with pharmaceutical companies focusing on novel drugs, medtech firms advancing sleep monitoring devices, and digital health companies developing AI-powered platforms. Competition increasingly revolves around integrated care models combining pharmacology, devices, and behavioral therapies.
Conclusion
The circadian rhythm sleep disorders market is projected to expand from USD 880 million in 2024 to USD 1.55 billion by 2034, at a CAGR of 5.8%.
This report is also available in the following languages : Japanese (概日リズム睡眠障害市場), Korean (생체 리듬 수면 장애 시장), Chinese (昼夜节律睡眠障碍市场), French (Marché des troubles du sommeil liés au rythme circadien), German (Markt für zirkadiane Rhythmus-Schlafstörungen), and Italian (Mercato dei disturbi del ritmo circadiano del sonno), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72108
Our More Reports:
Neurotrophic Keratitis Market
https://exactitudeconsultancy.com/reports/72236/neurotrophic-keratitis-market
Optic Neuritis Market
https://exactitudeconsultancy.com/reports/72238/optic-neuritis-market
Thyroid Eye Disease Market
https://exactitudeconsultancy.com/reports/72240/thyroid-eye-disease-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Circadian Rhythm Sleep Disorders Market New Product Development & Latest Trends here
News-ID: 4190056 • Views: …
More Releases from Exactitude Consultancy
Intracranial Aneurysms Market to Grow at 5.7% CAGR, Reaching USD 4.2 Billion by …
Introduction
An intracranial aneurysm is an abnormal bulging or ballooning in a blood vessel of the brain, which can rupture and lead to life-threatening hemorrhagic stroke. While many aneurysms remain unruptured and asymptomatic, the risk of rupture presents a critical public health challenge.
The rising prevalence of hypertension, smoking, and aging populations, combined with increased adoption of neuroimaging and minimally invasive interventions, is fueling growth in the intracranial aneurysms market. Continuous innovations…
Interventional Neuroradiology Market to Set Phenomenal Growth From 2025 to 2034
Introduction
Interventional neuroradiology (INR) is a subspecialty of radiology focused on minimally invasive image-guided procedures for diagnosing and treating neurovascular disorders. Techniques such as endovascular coiling, stenting, embolization, and thrombectomy are widely used to manage stroke, aneurysms, arteriovenous malformations, and other cerebrovascular diseases.
The global burden of stroke and neurovascular disorders, combined with increasing adoption of minimally invasive treatments, is propelling the growth of the interventional neuroradiology market. With technological advances, rising…
Carotid Stenotic Scan Devices Market Detailed Industry Report Analysis 2025-2034
Introduction
Carotid stenosis, the narrowing of the carotid arteries caused by atherosclerotic plaque buildup, is a major risk factor for ischemic stroke. With stroke being one of the leading causes of death and disability worldwide, early detection of carotid stenosis through advanced diagnostic tools is critical for prevention and timely intervention.
Carotid stenotic scan devices-including ultrasound, CT angiography (CTA), magnetic resonance angiography (MRA), and Doppler technologies-play an essential role in assessing blood…
Adult Intraventricular Haemorrhage Market Massive Growth opportunity Ahead
Introduction
Adult Intraventricular Haemorrhage (IVH) is a severe neurological condition involving bleeding into the brain's ventricular system. While commonly associated with premature infants, IVH in adults often results from trauma, aneurysm rupture, stroke, or complications from neurosurgical procedures. It is a life-threatening emergency that requires immediate intervention and long-term rehabilitation.
The increasing burden of stroke, traumatic brain injuries, and vascular abnormalities is fueling demand for advanced neurosurgical tools, critical care monitoring, and…
More Releases for Pharmaceutical
Metronidazole Market 2023 Latest Innovations and Outlook By Players - Hongyuan P …
The Metronidazole Market 2023 study focuses on a global evaluation of information from the most recent market developments. The purpose of MarketsandResearch.biz is to offer the company's customers a comprehensive market overview to formulate development plans.
Designing of the report is done with the help of infographics, charts, and graphs. The report initially analyzes the various segments of the global Metronidazole market in a brief manner, which includes product types, applications.…
Hyperthyroidism Treatment Market Analytical Overview and Future | Merck, Herbran …
The Hyperthyroidism Treatment market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with development…
Mevastatin Market Is Booming Worldwide |Zhejiang Hisun Pharmaceutical, Guangdong …
Global Mevastatin Market Size research report 2022 offers in-depth assessment of revenue growth, market definition, segmentation, industry potential, influential trends for understanding the future outlook and current prospects for the market. This study provides information about the sales and revenue during the historic and forecasted period of (2022 to 2028). Understanding the segments helps in identifying the importance of different factors that aid market growth. Estimations about the CAGR value for…
Global Specialty Pharmaceutical Market Driving Future Growth on Specialty Pharma …
Global Specialty Pharmaceutical Industry Synopsis:
The Specialty Pharmaceutical Market report provides a detailed analysis of this business space. The market is analyzed in terms of production as well as consumption. Based on the production aspect, the report includes particulars pertaining to the manufacturing processes of the product, alongside revenue and gross margins of the respective manufacturers.
The Global Specialty Pharmaceutical Market will reach xxx Million USD in 2020 with CAGR xx%…
Metronidazole Market to 2023 (+5% CAGR Expected) Top Player Profiles – Hongyua …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2724380?utm_source=Anil&utm_medium=OPR
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in…
Metronidazole Market by Top Key Participant Hongyuan Pharmaceutical, Yinhe Aarti …
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Get Sample Copy of this Report @ https://www.researchbeam.com/global-metronidazole-2018-by-manufacturers-regions-type-and-application-forecast-to-2023-market/request-sample?utm_source=Anil
Scope of the Report:
This report focuses on the Metronidazole in global market, especially in North…
